Skip to content
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
Regenerative plasma
Brazilian SARS-CoV-2 P.1 differentiation exhibits resistance to antibody neutralization
Researchers monitor rapid rise of plasma SARS-CoV-2 antibodies over the course of a pandemic
New mutations in SARS-Cov-2 could appear during breast infection, scientists say
Ebola relapse experienced a recovery in antibody levels after recovery
Antibodies and inflammatory symptoms may help identify COVID-19 cases and predict their severity.
Continuous shedding and several mutations 154 days after initial SARS-CoV-2 report
Anti-SARS-CoV-2 antibodies administered by NTD protect against lethal infection
Cross-reactivated coronavirus antibodies modulate COVID-19 convalescent plasma action
-1.jpg?fit=300%2C300&ssl=1 "Researchers monitor rapid rise of plasma SARS-CoV-2 antibodies over the course of a pandemic")
.jpg?fit=300%2C300&ssl=1 "Anti-SARS-CoV-2 antibodies administered by NTD protect against lethal infection")
